Literature DB >> 8262968

Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex.

A Peña1, C D Reddy, S Wu, N J Hickok, E P Reddy, G Yumet, D R Soprano, K J Soprano.   

Abstract

The presence of a CACGTG element within a region of the human ornithine decarboxylase (ODC) promoter located at -491 to -474 base pairs 5' to the start site of transcription suggested that the c-Myc.Max protein complex may play a role in the regulation of ODC expression during growth. Electrophoretic mobility shift assays and methylation interference analysis showed that the nuclei of WI-38 cells expressing ODC contained proteins that bound to this region of the ODC gene in a manner that correlated with growth-associated ODC expression. Also, use of antibodies against c-Myc and Max and purified recombinant c-Myc and Max protein in the electrophoretic mobility shift assay confirmed that these proteins can specifically bind this portion of the human ODC promoter. Transient transfection studies showed that increase in the level of c-Myc and/or Max led to a significant enhancement of expression of a human ODC promoter-CAT reporter construct. Moreover, treatment of actively growing WI-38 cells with an antisense oligomer to c-Myc reduced the amount of endogenous protein complex formed and the amount of endogenous ODC mRNA expressed. These studies show that the c-Myc.Max protein complex plays a role in the transcriptional regulation of human ODC in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262968

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Specific requirement of putrescine for the mitogenic action of juvenile hormone on adult insect neuroblasts.

Authors:  M Cayre; C Strambi; P Charpin; R Augier; A Strambi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene.

Authors:  B C Lewis; H Shim; Q Li; C S Wu; L A Lee; A Maity; C V Dang
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 3.  DFMO: targeted risk reduction therapy for colorectal neoplasia.

Authors:  Christina M Laukaitis; Eugene W Gerner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-08       Impact factor: 3.043

4.  Panagrellus redivivus ornithine decarboxylase: structure of the gene, expression in Escherichia coli and characterization of the recombinant protein.

Authors:  G Niemann; H von Besser; R D Walter
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

5.  A role for c-myc in chemically induced renal-cell death.

Authors:  Y Zhan; J L Cleveland; J L Stevens
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

6.  Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis.

Authors:  Arup Maiti; Muriel Cuendet; Tamara Kondratyuk; Vicki L Croy; John M Pezzuto; Mark Cushman
Journal:  J Med Chem       Date:  2007-01-25       Impact factor: 7.446

7.  B23 is a downstream target of polyamine-modulated CK2.

Authors:  Kathryn Lawson; Laura Larentowicz; Lisa Laury-Kleintop; Susan K Gilmour
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

Review 8.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

9.  A minimal regulatory region maintains constitutive expression of the max gene.

Authors:  M A Peters; K G Sollenberger; T L Kao; E J Taparowsky
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

10.  Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells.

Authors:  Sudha Mannava; Vladimir Grachtchouk; Linda J Wheeler; Michael Im; Dazhong Zhuang; Elena G Slavina; Christopher K Mathews; Donna S Shewach; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2008-06-03       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.